期刊文献+

Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection 被引量:1

Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection
原文传递
导出
摘要 High performance liquid chromatography was coupled with UV detection for simultaneous quantification of lopinavir (LPV) and ritonavir (RTV) in human plasma. This assay was sensitive, accurate and simple, and only used 200 μL of plasma sample. Samples were liquid-liquid extracted, and diazepam was used as an internal standard. The chromatographic separation was achieved on a C18 reversed-phase analytic column with a mobile phase of acetonitrile-sodium dihydrogen phosphate buffer (10 mmol L 1, pH 4.80) (60:40, v/v). UV detection was conducted at 205 nm and the column oven was set at 40°C. Calibration curves were constructed between 0.5-20 μg mL 1 for LPV and 0.05-5 μg mL 1 for RTV. The relative standard deviations were 2.16%-3.20% for LPV and 2.12%-2.60% for RTV for intra-day analysis, and 2.34%-4.04% for LPV and 0.31%-4.94% for RTV for inter-day analysis. The accuracy was within 100%±10%. The mean extraction recoveries were 79.17%, 52.26% and 91.35% for RTV, LPV and diazepam, respectively. This method was successfully applied to human plasma samples from patients orally administered a salvage regimen of lopinavir-ritonavir tablets. High performance liquid chromatography was coupled with UV detection for simultaneous quantification of lopinavir (LPV) and ritonavir (RTV) in human plasma. This assay was sensitive, accurate and simple, and only used 200μL of plasma sample. Samples were liquid-liquid extracted, and diazepam was used as an internal standard. The chromatographic separation was achieved on a C18 reversed-phase analytic column with a mobile phase of acetonitrile-sodium dihydrogen phosphate buffer (10 mmol L-1, pH 4.80) (60:40, v/v). UV detection was conducted at 205 nm and the column oven was set at 40℃. Calibration curves were constructed between 0,5-20 μg mL-1 for LPV and 0.05-5 μg mL-1 for RTV. The relative standard deviations were 2.16%-3.20% for LPV and 2.12%-2.60% for RTV for intra-day analysis, and 2.34%-4.04% for LPV and 0.31%-4.94% for RTV for inter-day analysis. The accuracy was within 100%+10%. The mean extraction recoveries were 79.17%, 52.26% and 91.35% for RTV, LPV and diazepam, respectively. This method was successfully applied to human plasma samples from patients orally administered a salvage regimen of lopinavir-ritonavir tablets.
出处 《Science China(Life Sciences)》 SCIE CAS 2012年第4期321-327,共7页 中国科学(生命科学英文版)
基金 supported by the National Key Technologies R&D Program for the 11th Five-year Plan (Grant No. 2008ZX10001-006) the Key Clinical Program of the Ministry of Health 2010-2012
关键词 高效液相色谱法 人血浆 紫外检测器 定量分析 相对标准偏差 UV检测 RTV 磷酸二氢钠 lopinavir, ritonavir, HPLC, UV detection, human plasma
  • 相关文献

参考文献25

  • 1Barragan P,Podzamczer D. Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment. Expert Opin Pharmacother,2008,9: 2363-2375.
  • 2Cvetkovic R S,Goa K L. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs,2003,63: 769-802.
  • 3Kaplan S S,Hicks C B. Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection. Expert Opin Pharmacother,2005,6: 1573-1585.
  • 4Manosuthi W,Kiertiburanakul S,Amornnimit W,et al. Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure. AIDS Res Ther,2009,6: 30.
  • 5Josephson F,Andersson M C,Flamholc L,et al. The relation between treatment outcome and efavirenz,atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patients. Eur J Clin Pharmacol,2010,66: 349-357.
  • 6Hsu A,Isaacson J,Brun S,et al. Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother,2003,47: 350-359.
  • 7DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1nfected Adults and Adolescents. 2009. http://AIDSinfonihgov.
  • 8Gutierrez F,Padilla S,Navarro A,et al. Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens. J Acquir Immune Defic Syndr, 2003,33: 594-600.
  • 9Hammer S M,Eron J J Jr.,Reiss P,et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. Jama,2008,300: 555-570.
  • 10Thompson M A,Aberg J A,Cahn P,et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. Jama,2010,304: 321-333.

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部